Carl Elliott on Human Subjects and Big Pharma

from the NYT, July 28th, an Op-Ed piece by bioethicist Carl Elliott:

LAST month, the Archives of Internal Medicine published a scathing reassessment of a 12-year-old research study of Neurontin, a seizure drug made by Pfizer. The study, which had included more than 2,700 subjects and was carried out by Parke-Davis (now part of Pfizer), was notable for how poorly it was conducted. The investigators were inexperienced and untrained, and the design of the study was so flawed it generated few if any useful conclusions. Even more alarming, 11 patients in the study died and 73 more experienced “serious adverse events.” Yet there have been few headlines, no demands for sanctions or apologies, no national bioethics commissions pledging to investigate. Why not?

Here is the complete article.

What sorts on psychiatry

Here are a few What sorts posts on psychiatry

Does anyone remember “lobotomy”?

Is your dog on prozac?

Marcia Angell on Big Pharma

NYT on DSM-V

Defending Electroshock

What sorts of people?  Empathy deficit disorder–do you suffer from it?

Pride in maddness–the new visibility